Cargando…
Toll-like receptor 4 in COVID-19: friend or foe?
Toll-like receptor 4, an innate immune sensor, is one of the key ‘fate-deciding’ regulators of immunity as well as COVID-19 immunopathogenesis. Suitable targeting of Toll-like receptor 4 appears to be an effective strategy to counteract the pandemic.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017673/ https://www.ncbi.nlm.nih.gov/pubmed/35462619 http://dx.doi.org/10.2217/fvl-2021-0249 |
_version_ | 1784688825484705792 |
---|---|
author | Mukherjee, Suprabhat |
author_facet | Mukherjee, Suprabhat |
author_sort | Mukherjee, Suprabhat |
collection | PubMed |
description | Toll-like receptor 4, an innate immune sensor, is one of the key ‘fate-deciding’ regulators of immunity as well as COVID-19 immunopathogenesis. Suitable targeting of Toll-like receptor 4 appears to be an effective strategy to counteract the pandemic. |
format | Online Article Text |
id | pubmed-9017673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-90176732022-04-22 Toll-like receptor 4 in COVID-19: friend or foe? Mukherjee, Suprabhat Future Virol Editorial Toll-like receptor 4, an innate immune sensor, is one of the key ‘fate-deciding’ regulators of immunity as well as COVID-19 immunopathogenesis. Suitable targeting of Toll-like receptor 4 appears to be an effective strategy to counteract the pandemic. Future Medicine Ltd 2022-04-19 2022-03 /pmc/articles/PMC9017673/ /pubmed/35462619 http://dx.doi.org/10.2217/fvl-2021-0249 Text en © 2022 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Editorial Mukherjee, Suprabhat Toll-like receptor 4 in COVID-19: friend or foe? |
title | Toll-like receptor 4 in COVID-19: friend or foe? |
title_full | Toll-like receptor 4 in COVID-19: friend or foe? |
title_fullStr | Toll-like receptor 4 in COVID-19: friend or foe? |
title_full_unstemmed | Toll-like receptor 4 in COVID-19: friend or foe? |
title_short | Toll-like receptor 4 in COVID-19: friend or foe? |
title_sort | toll-like receptor 4 in covid-19: friend or foe? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017673/ https://www.ncbi.nlm.nih.gov/pubmed/35462619 http://dx.doi.org/10.2217/fvl-2021-0249 |
work_keys_str_mv | AT mukherjeesuprabhat tolllikereceptor4incovid19friendorfoe |